Salidroside rescued mice from experimental sepsis through anti-inflammatory and anti-apoptosis effects

Abstract Background Salidroside (SDS) is the main effective component of Rhodiola rosea L with a variety of pharmacologic properties. The objective of this study was to investigate the efficacy of SDS in the treatment of experimental sepsis in mice and explore the possible underlying action mechanis...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of surgical research Vol. 195; no. 1; pp. 277 - 283
Main Authors Liu, Shanshan, MD, Yu, Xiongwei, MD, Hu, Baoji, MD, Zou, Yun, MD, Li, Jinbao, MD, PhD, Bo, Lulong, MD, PhD, Deng, Xiaoming, MD, PhD
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.05.2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Background Salidroside (SDS) is the main effective component of Rhodiola rosea L with a variety of pharmacologic properties. The objective of this study was to investigate the efficacy of SDS in the treatment of experimental sepsis in mice and explore the possible underlying action mechanisms. Methods Sepsis was induced in C57BL/6 male mice via cecal ligation and puncture (CLP). The animals were divided into three groups as follows: sham, CLP, and CLP plus SDS. SDS (50 mg/kg) was injected intraperitoneally 1 h after operation. Postoperative survival of the mice, bacterial clearance in blood and peritoneal lavage fluid, cytokine secretion in blood, and histology of lung were evaluated. In addition, apoptosis of immune cells in the spleen and thymus were examined, respectively. Results SDS administration prolonged the survival of the septic mice, inhibited the proinflammatory responses, and enhanced bacterial clearance. It also alleviated the pathologic changes in the lung and inhibited the apoptosis of immune cells in the spleen and thymus after CLP challenge. Conclusions SDS exerts a protective effect in CLP-induced sepsis by attenuating the proinflammatory responses, enhancing bacterial clearance, and preserving adaptive immunity. SDS may be a promising therapeutic strategy for the treatment of sepsis.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-4804
1095-8673
DOI:10.1016/j.jss.2015.01.021